The ultimate goal? It depends.
The knowledge that cervical cancer should be a preventable disease has provided the impetus to improve the Pap smear. Now, for the first time in 50 years, two new computerized technologies are available--the AutoPap and Papnet systems--that could change the way they are interpreted. Of course, these new innovations come at a price, perhaps doubling or tripling the cost--by one estimate, the new technologies could add $1 billion per year. The health policy issue is whether these innovations address the limitations of cervical cancer screening programs in an efficient way. The analysis is entirely different when cast as an individual patient care issue. Here the patient and physician, who serves as her advocate, want to use the best screening method. The goal is not how to best allocate resources to improve the health of the overall population, but instead how to get the best care for the individual patient.
Brown
E
E
D003362:Cost-Benefit Analysis; D003936:Diagnosis, Computer-Assisted / Q000191:economics / Q000639:trends*; D005260:Female; D006297:Health Services Accessibility; D006801:Humans; D065006:Papanicolaou Test; D013673:Technology Assessment, Biomedical; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000517:prevention & control; D014626:Vaginal Smears / Q000191:economics / Q000379:methods*